Details for Patent: 10,238,640

Which drugs does patent 10,238,640 protect, and when does it expire?

Patent 10,238,640 protects CHILDREN'S ADVIL ALLERGY SINUS and CHILDREN'S ADVIL-FLAVORED and is included in two NDAs.

This patent has nine patent family members in eight countries.

Summary for Patent: 10,238,640

Title:	Pharmaceutical suspension composition
Abstract:	An aqueous oral liquid pharmaceutical composition system with reduced propensity for agglomeration and phase separation which is particularly amendable to the suspension of one or more pharmaceutical actives that are substantially insoluble in water. The oral liquid pharmaceutical composition may further comprise pharmaceutical actives that are soluble in water and dissolve in the aqueous medium. In the composition of the invention both suspended and any dissolved active agents are distributed homogeneously.
Inventor(s):	Dickerson; Jay (Midlothian, VA), Mark; William (Glen Allen, VA), Trimmer; Annabelle (Manakin-Sabot, VA), Jaeger; David (Chester, VA), Alley; Amanda (Midlothian, VA)
Assignee:	Wyeth LLC (New York, NY)
Application Number:	15/349,101
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound;

Drugs Protected by US Patent 10,238,640

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Glaxosmithkline	CHILDREN'S ADVIL ALLERGY SINUS	chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride	SUSPENSION;ORAL	021587-001	Feb 24, 2004		OTC	Yes	Yes			Y
Glaxosmithkline	CHILDREN'S ADVIL-FLAVORED	ibuprofen	SUSPENSION;ORAL	020589-002	Nov 7, 1997		OTC	No	No			Y

International Family Members for US Patent 10,238,640

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2567075
China	1988893
European Patent Office	1748765
European Patent Office	2465497
Mexico	PA06013481
Turkey	200501948
Taiwan	200600118